Recruiting
Otitis media+1
RecruitingStudy on Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps and Eosinophilic Otitis Media
Registered drugNo placebo
Study on Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps and Eosinophilic Otitis Media
Registered drugNo placebo
- Disease:Otitis mediaChronic rhinosinusitis with nasal polyps
- Substances:Dupilumab
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Dupilumab
- Sponsor:Amsterdam UMC Stichting

